| HOME >> BIOLOGY >> TECHNOLOGY |
Property and equipment, net 812,115 321,159
Other assets 16,422 54,016
Total assets $4,565,707 $5,854,868
Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable $686,029 $560,641
Accrued rent 32,701 19,340
Accrued payroll 176,158 414,519
Accrued vacation 199,538 156,234
Accrued other expenses 139,612 -
Current portion of capital lease
obligations 54,518 32,443
Total current liabilities 1,288,556 1,183,177
Capital lease obligations, net of
current portion 38,612 73,451
Minority interest 984,583 -
Commitment and contingencies - -
Stockholders' equity :
Preferred Stock, $0.001 par value;
10,000,000 shares authorized; no
shares issued and outstanding - -
Common Stock: $0.001 par value;
300,000,000 shares authorized;
24,830,932 and 23,217,846 shares
issued and outstanding at
September 30, 2008 and December
31, 2007 24,831 23,218
Additional paid-in capital 20,326,298 16,527,929
Accumulated deficit (18,073,315) (11,952,907)
Accumulated other comprehensive
income (23,858) -
Total stockholders' equity 2,253,956 4,598,240
<
'/>"/>
| SOURCE WaferGen Biosystems, Inc. Copyright©2008 PR Newswire. All rights reserved |